Medium sized lactones with hypolipidaemic and antioxidant activity: Synthesis and biological evaluation of promising dual-action anti-atherosclerosis drugs

Bioorganic and Medicinal Chemistry

Volumn 7, Issue 2, 1999, Pages 411-418

  Baldazzi, Claudia ^b   Calderoni, Francesca ^d   Marotta, Emanuela ^a   Piani, Silvano ^b   Righi, Paolo ^a   Rosini, Goffredo ^a   Saguatti, Stefano ^b   Tiozzo, Roberta ^c   Calandra, Sebastiano ^c   Venturelli, Francesca ^d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Alfa Wassermann SpA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d NONE

Author keywords

Antioxidants; Hypolipidaemics; Medium sized lactones; Radical scavengers

Indexed keywords

ANTILIPEMIC AGENT; LACTONE DERIVATIVE;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CHEMICAL MODIFICATION; CYTOTOXICITY; DRUG ACTIVITY; DRUG SYNTHESIS; HEPATOMA CELL; HUMAN; LIPID OXIDATION; LIPOGENESIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ANTILIPEMIC AGENTS; ANTIOXIDANTS; ARTERIOSCLEROSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CYTOTOXICITY TESTS, IMMUNOLOGIC; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; LACTONES; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, CHEMICAL; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS;

EID: 0033051084     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(98)00252-1     Document Type: Article

References (33)

1. Ross, R. N. Engl. J. Med. 1986, 314, 488.
2. Ross, R. Am. J. Pathol. 1993, 143, 987.
3. Steinberg, D. JAMA 1985, 253, 2080.
4. Steinberg, D. Arteriosclerosis 1983, 3, 283.
5. Steinberg, D.; Parthasarathy, S.; Carew, T. E.; Khoo, J. C.; Witztum, J. L. N. Engl. J. Med. 1989, 320, 915.
6. Esterbauer, H.; Waeg, G.; Puhl. H. Br. Med. Bull. 1993, 49, 566.
7. D. Steinberg showed the presence of antibodies anti-OX-LDL and of OX-LDL, oxidized low density lipoproteins, in the atheromatous lesions of patients suffering from advanced atherosclerosis. Moreover, OX-LDL appeared toxic towards the endothelial cells and a pro-inflammatory activity towards monocytes and lymphocytes and an increased susceptibility to the taking from the macrophages and the smooth muscle cells with formation of foam cells was showed. Such properties can have an important part in the processes of formation and progression of the atheromatous lesion.
8. Witztum, J. L.; Steinberg. D. J. Clin. Invest. 1991, 88, 1785.
9. Ross, R. Nature 1993, 362, 801.
10. Burton, G. W.; Ingold, K. U. Acc. Chem. Res. 1989, 19, 194.
11. Hall, E. D.; Braughler, J. M. Free Radical Biol. Med. 1989, 6, 303.
12. Van Acker, S. A. B. E.; Koymans, L. M. H.; Bast, A. Free Radical Biol. Med. 1993, 15, 311.
13. Carew, T. E.; Schwenke, D. C.; Steinberg, D. Proc. Natl. Acad. Sci. USA 1987, 84, 7725.
14. Esterbauer, H.; Dieber-Rotheneder, M.; Striegl, G.; Waeg, G. Am. J. Clin. Nutr. 1991, 53, 314S.
15. Kita, T.; Nagano, Y.; Yokode, M.; Ishii, K.; Kume, N.; Ooshima, A.; Yoshida, H.; Kawai, C. Proc. Natl. Acad. Sci. USA 1987, 84, 5928.
16. Rimm, E. B.; Stampfer, M. J.; Ascherio, A.; Giovannucci, E.; Colditz, G. A.; Willet, W. C. New Engl. J. Med. 1993, 328, 1450.
17. Stampfer, M. J.; Hennekens, C. H.; Manson, J. E.; Colditz, G. A.; Rosner, B.; Willet, W. C. New Engl. J. Med. 1993, 328, 1444.
18. Generally, the best reductions of the plasma LDL have been obtained by means of the resins sequestering the bile acids and with the statins, inhibitors of the HMGCoA reductase, while the plasma levels of the triglycerides are mostly affected by the treatment with nicotinic acid and fibrates. Betteridge, D. J. Curr. Opin. Lipidol. 1993, 4, 49.
19. Scott, J. W.; Bizzarro, F. T.; Parrish, D. R.; Saucy, G. Helv. Chim. Acta 1976, 59, 290.
20. Gerlach, H.; Thalmann, A. Helv. Chim. Acta 1974, 57, 2661.
21. Corey, E. J.; Nicolaou, K. C. J. Am. Chem. Soc. 1974, 96, 5614.
22. Steinbrecher, U. P. J. Biol. Chem. 1987, 262, 3603.
23. Vanderyse, L.; Dvreese, A. M.; Baert, J.; Vanloo, B.; Lins, L.; Ruysschaert, J. M.; Rosseneu, M. Atherosclerosis 1992, 97, 187.
24. Laemmli, U. K. Nature 1970, 227, 680.
25. Fong, L. G.; Parthasarathy, S.; Witsum, J. L.; Steinberg, D. J. Lipid Res. 1987, 28, 1466.
26. Cingi, R.; De Angelis, I.; Fortunati, E.; Reggiani, D.; Bianchi, V.; Tiozzo, R.; Zucco, F. Toxicol. in vitro 1991, 5, 119.
27. Barnhard, J. W.; Li, D. L. Am. J. Cardiol. 1988, 62, 52B.
28. Gherardi, E.; Calandra, S. Lipids 1980, 15, 108.
29. Skipski, V. P.; Smolowe, A. F.; Sullivan, M.; Barklay, J. Biochem. Biophys. Acta 1965, 106, 386.
30. Rosini, G.; Baldazzi, C.; Romagnoli, E.; Saguatti, S.; Piani, S. Eur. Patent Appl. 1996, EP 718295 A1; US Patent 5,608,084, 1997; Chem Abs. 1996, 125, 114726.
31. Havel, R. J.; Eder, H. A.; Bragdon, J. H. J. Clin. Invest. 1955, 34, 1345.
32. Lowry, O. H.; Rosebrough, N. J.; Farr, A. L.; Randall, R. J. J. Biol. Chem. 1951, 193, 265.
33. Fleisher, S. In Methods in Enzymology; Packer, L., Ed.; New York Press: New York, 1978; Vol. 52.